ACHV ACHIEVE LIFE SCIENCES, INC.

Nasdaq achievelifesciences.com


$ 4.16 $ 1.12 (36.36 %)    

Friday, 17-Oct-2025 19:30:57 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 4.2
$ 3.99
$ 4.05 x 100
$ 4.20 x 105
$ 3.71 - $ 4.44
$ 1.84 - $ 5.31
15,968,800
na
214.64M
$ 1.47
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-11-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-16-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-10-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-11-2021 12-31-2020 10-K
20 11-12-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-14-2020 03-31-2020 10-Q
23 03-13-2020 12-31-2019 10-K
24 11-06-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-15-2019 03-31-2019 10-Q
27 03-14-2019 12-31-2018 10-K
28 11-07-2018 09-30-2018 10-Q
29 08-08-2018 06-30-2018 10-Q
30 05-09-2018 03-31-2018 10-Q
31 03-01-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 07-31-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 02-23-2017 12-31-2016 10-K
36 11-10-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-12-2016 03-31-2016 10-Q
39 03-09-2016 12-31-2015 10-K
40 11-12-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 fda-unveils-first-experimental-drugs-under-fast-track-voucher-plan-to-cut-drug-review-times

The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, a...

 achieve-life-sciences-appoints-craig-donnelly-to-coo

- Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage specialty pharmaceutical company focused on the global development an...

 achieve-life-sciences-inches-closer-to-fda-nod-for-first-new-quit-smoking-drug-in-20-years

HC Wainwright backs Achieve Life Sciences with a Buy rating as cytisinicline nears potential 2026 FDA approval, targeting a lar...

 hc-wainwright--co-initiates-coverage-on-achieve-life-sciences-with-buy-rating-announces-price-target-of-12

HC Wainwright & Co. analyst Brandon Folkes initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Buy rating a...

 achieve-life-sciences-q2-eps-037-beats-038-estimate

Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of...

 achieve-life-sciences-q1-eps-037-inline

Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.37) per share which met the analyst consensus estimate. Th...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION